ArticleMolecular oncology2024

Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.

Emilia Alors-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.